Skip to main content
. Author manuscript; available in PMC: 2014 Feb 4.
Published in final edited form as: Kidney Int. 2013 May 29;84(5):1009–1016. doi: 10.1038/ki.2013.206

Table 1.

| Detailed patient characteristics

Patient no./sex/age (years) Race/ethnic
groupa 		ESRD cause No. of
previous
transplants		 KPD donor
age (years)		 HLA
mismatchb 		Blood
group		 cPRA%c Dialysis
time
d (months)		 KPD
wait-time
e (months)
DSA(+) KPD (n=12)
  1/F/49 Black Lupus 0 56 4/6 O+ 97 74 5.5
  2/M/57 White Diabetes 1 56 4/6 B+ 100 22 6
  3/M/66 White FSGS 1 44 6/6 A+ 68 54 14
  4/M/38 White FSGS 1 48 5/6 B+ 100 73 3.5
  5/F/62 White PCKD 0 41 5/6 A+ 99 94 6
  6/F/67 White IgA 0 60 6/6 O+ 63 29 11
  7/F/69 White FSGS 0 50 6/6 O+ 99 12 15
  8/F/66 White PCKD 0 42 5/6 O+ 69 0 4.5
  9/F/51 Hispanic PCKD 0 60 3/6 O+ 98 32 7
  10/F/28 Hispanic HTN 0 42 5/6 O+ 27 0 2
  11/F/44 White HTN 0 47 4/6 O− 89 4 5
  12/F/68 Asian HTN 0 43 4/6 B+ 99 37 3
DSA(−)KPD (n=10)
  13/F/52 Asian Lupus 0 44 2/6 A+ 92 18 2
  14/F/42 Black HTN 0 31 3/6 O− 76 60 5
  15/M/45 Asian IgA 0 55 6/6 AB+ 27 42 To wait-listf
  16/F/43 White HTN 0 56 4/6 AB+ 88 65 To wait-listf
  17/M/43 Asian Diabetes 1 60 6/6 O+ 87 23 7
  18/F/38 Asian Diabetes 0 37 3/6 A+ 98 39 15
  19/F/47 White FSGS 0 46 5/6 B+ 65 14 6
  20/F/46 Other MGN 0 64 3/6 AB− 75 45 To wait-listf
  21/M/34 Asian HTN 1 56 3/6 O+ 98 38 2
  22/F/57 Hispanic Diabetes 0 49 4/6 O+ 82 81 3

Abbreviations: cPRA, calculated panel reactive antibody; DSA, donor-specific antibody; ESRD, end-stage renal disease; F, female; FSGS, focal segmental glomerulosclerosis; HLA, human leukocyte antigen; HTN, hypertension; IgA, immunoglobulin A; KPD, kidney paired donation; M, male; MGN, membranous glomerulonephritis; PCKD, polycystic kidney disease.

a

Patient race/ethnic group is self-reported.

b

HLA mismatch based on HLA-A, B, and DR loci.

c

cPRA based on unacceptable antigens using the UNOS calculator (http://optn.transplant.hrsa.gov/resources/allocationcalculators.asp?index=78).

d

Dialysis time for repeat-transplant patients is measured from time of renal transplant failure to transplant date. Patients with `0' dialysis time were transplanted preemptively.

e

KPD wait-time is measured from recipient list-date in to the National Kidney Registry matching database to the actual date of transplantation.

f

Patient without willing living donor who received living-donor renal transplant from KPD pool while on deceased-donor waiting list.